+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Brinzolamide"

Optic Nerve Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Optic Nerve Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Antiglaucoma Drugs Global Market Report 2024 - Product Thumbnail Image

Antiglaucoma Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
Global and Chinese Brinzolamide Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Brinzolamide Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 143 Pages
  • China, Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Brinzolamide is a carbonic anhydrase inhibitor used to treat ocular hypertension and glaucoma. It is a topical ophthalmic solution that works by decreasing the amount of fluid in the eye, thereby reducing intraocular pressure. It is often used in combination with other medications to treat glaucoma. Brinzolamide is available in both generic and brand-name formulations. Common side effects include stinging, burning, and redness of the eyes. Brinzolamide is a key component of the optical disorders drugs market. It is used to treat a variety of ocular conditions, including glaucoma, ocular hypertension, and uveitis. It is also used to reduce the risk of vision loss in patients with glaucoma. Brinzolamide is a cost-effective treatment option for many patients, as it is available in both generic and brand-name formulations. Some companies in the Brinzolamide market include Alcon, Allergan, Bausch + Lomb, and Santen Pharmaceuticals. Show Less Read more